Sanjivani Paranteral Limited (BOM:531569)

India flag India · Delayed Price · Currency is INR
145.75
-4.20 (-2.80%)
At close: May 27, 2026
Market Cap1.84B -31.6%
Revenue (ttm)686.66M -2.0%
Net Income67.86M -16.2%
EPS5.49 -17.6%
Shares Out 12.28M
PE Ratio27.31
Forward PEn/a
Dividend0.50 (0.33%)
Ex-Dividend Daten/a
Volume8,483
Open153.70
Previous Close149.95
Day's Range144.00 - 153.70
52-Week Range126.00 - 268.80
Beta-0.34
Analystsn/a
Price Targetn/a
Earnings DateMay 14, 2026

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering ... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 40
Stock Exchange Bombay Stock Exchange
Ticker Symbol 531569
Full Company Profile

Financial Performance

In fiscal year 2026, Sanjivani Paranteral's revenue was 686.66 million, a decrease of -2.04% compared to the previous year's 700.99 million. Earnings were 67.86 million, a decrease of -16.20%.

Financial Statements